Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 6Other hematologic neoplasm 4Genitourinary 1Dermatologic 1Breast 1

Conditions

Prostatic Neoplasms 2Breast Neoplasms 2Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Salivary Gland Neoplasms 1Rectal Neoplasms 1Pancreatic Neoplasms 1Neoplasms 1Lymphoma 1Kidney Neoplasms 1Gastrointestinal Stromal Tumors 1Gallbladder Neoplasms 1Esthesioneuroblastoma, Olfactory 1Esophageal Neoplasms 1Endometrial Neoplasms 1Colonic Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Ovarian Epithelial 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Bile Duct Neoplasms 1Appendiceal Neoplasms 1Anus Neoplasms 1

Interventions

Cyclophosphamide 8pembrolizumab 6Filgrastim 5Busulfan 5fludarabine phosphate 4fludarabine 4Nivolumab 4Flow Cytometry 4Antilymphocyte Serum 4Alemtuzumab 4Tacrolimus 3Stem Cell Transplantation 3Sirolimus 3Radiotherapy 3Peripheral Blood Stem Cell Transplantation 3Paclitaxel 3Mycophenolic Acid 3Melphalan 3Dexamethasone 3Carboplatin 3Biopsy 3Azacitidine 3valspodar 2atezolizumab 2aldesleukin 2X-Rays 2Vorinostat 2Vincristine 2Thiotepa 2Psychiatric Rehabilitation 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma × 7-hydroxystaurosporine × Genitourinary × Clear all
NCT00001444 2008-03-04

A Phase I Trial of Continuous Infusion UCN-01 in Patients With Refractory Neoplasms

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
51 enrolled
BreastGenitourinaryLymphoid

Breast Neoplasms, Lymphoma, Neoplasms, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡